Post-hemodialysis dosing of 1 vs. 2 g of ceftazidime in anuric end-stage renal disease patients on low-flux dialysis and its pharmacodynamic implications on clinical use-Reference-Cited by-同舟云学术

Post-hemodialysis dosing of 1 vs. 2 g of ceftazidime in anuric end-stage renal disease patients on low-flux dialysis and its pharmacodynamic implications on clinical use

Published:2015-10-20 Issue:2 Volume:20 Page:253-260
ISSN:1492-7535
Container-title:Hemodialysis International
language:en
Short-container-title:Hemodialysis International

Author:

Goh Jessica Hui Fen¹,Lee Siok Ying¹,Ooi Say Tat²,Lee Soon-U Lawrence³,Hee Kim-Hor³,Renaud Claude J.⁴

Affiliation:

1. Department of Pharmacy; Khoo Teck Puat Hospital; Singapore

2. Department of Medicine, Infectious Diseases Division; Khoo Teck Puat Hospital; Singapore

3. Yong Loo Lin School of Medicine; National University Singapore; Singapore

4. Department of Medicine, Nephrology Division; Khoo Teck Puat Hospital; Singapore

Funder

National Medical Research Council (NMRC) Singapore

Publisher

Wiley

Subject

Nephrology,Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hdi.12377/fullpdf

Reference26 articles.

1. Epidemiology, surveillance, and prevention of bloodstream infections in haemodialysis patients;Patel;Am J Kidney Dis,2010

2. Burden of Infection in patients with end- stage renal disease requiring long-term dialysis;Berman;Clin Infect Dis,2004

3. Association between prior peripherally inserted central catheters and lack of functioning arteriovenous fistulas: A case-control study in haemodialysis patients;El Ters;Am J Kidney Dis,2012

4. High-dose cefazolin on consecutive haemodialysis in anuric patients with Staphylococcal bacteremia;Renaud;Hemodial Int,2011

5. Intermittent administration of betalactam-antibiotics for treatment of severe infection in haemodialysis patients;Meyer;Eur J Med Res,2005

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Outcomes of Ceftazidime–Avibactam versus Ceftolozane–Tazobactam in Managing Pseudomonal Infections in Patients Undergoing Renal Replacement Therapy;Antibiotics;2024-07-26

2. Microbiologic outcomes of ceftazidime‐avibactam dosing in patients with sepsis utilizing renal replacement therapies;Hemodialysis International;2023-05-05

3. Therapeutic Drug Monitoring of Antibiotic Drugs in Patients Receiving Continuous Renal Replacement Therapy or Intermittent Hemodialysis: A Critical Review;Therapeutic Drug Monitoring;2022-02

4. Evaluation of OPAT in the Age of Antimicrobial Stewardship;Current Treatment Options in Infectious Diseases;2020-04-29

5. Anti-Infective Agents;Demystifying Drug Dosing in Renal Dysfunction;2019-05-31